Headlines

A Glimpse Into The Expert Outlook On AbbVie Through 15 Analysts

Latest Ratings for ABBV

Date Firm Action From To
Feb 2022 UBS Downgrades Buy Neutral
Feb 2022 Mizuho Maintains Buy
Feb 2022 Barclays Maintains Equal-Weight

View More Analyst Ratings for ABBV

View the Latest Analyst Ratings

read more

Join the newsletter

Subscribe to get our latest content by email.

    We respect your privacy. Unsubscribe at any time.

    Leave a Reply

    Your email address will not be published. Required fields are marked *